Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2002
12/05/2002CA2448639A1 Novel heterocyclic derivatives and medicinal use thereof
12/05/2002CA2448634A1 Novel heterocyclic compound and medicinal use thereof
12/05/2002CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002CA2448294A1 Method for treating fibrotic diseases or other indications vi
12/05/2002CA2448276A1 Method for treating glaucoma vi
12/05/2002CA2448198A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002CA2447234A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002CA2411549A1 Ligands of integrin receptors
12/04/2002EP1262475A1 Indole derivatives, process for preparation of the same and use thereof
12/04/2002EP1262180A1 Tnf-alpha inhibitors
12/04/2002EP1261606A1 Substituted oxazolidinones and their use in the field of blood coagulation
12/04/2002EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002EP1261603A1 Flavone derivatives, preparation method and use as medicines
12/04/2002EP1261600A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
12/04/2002EP1261591A1 7-nitro-2,1,3-benzoxadiazole derivatives and 7-nitro-2,1,3-benzthiadiazole derivatives and dyes, which contain these compounds and which are used for dying keratin fibers
12/04/2002EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors
12/04/2002EP1261327A2 Adenosine receptor modulators
12/04/2002EP1111993A4 Fused-benzene derivatives useful as herbicides
12/04/2002EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
12/04/2002CN1382688A Chromone compounds with antineoplastic activity and its open-loop products and preparing process
12/04/2002CN1382442A Method for preventing dyskinesia
12/03/2002US6489487 Triazolone derivatives, use thereof, and intermediates therefor
12/03/2002US6489478 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines
12/03/2002US6489452 An azo dye represented by the following general formula (1) and a process for making the azo dye is disclosed. the process comprises a step in which a diazonium salt is formed by the reaction between an aminopyrazole and aromatic coupling agent
12/03/2002US6489344 For treatment diabetes in a human or animal subject
12/03/2002US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002US6489322 Benzoxazepines as selective inhibitors of the neuronal isoform of nitric oxide synthase for treatment of neurodegenerative disease
12/03/2002US6489320 5, 5-disubstituted-1, 5-dihydro-4, 1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors
12/03/2002US6489314 Due to the increasing interest in epothilones as anti-cancer agents, novel derivatives of these compounds are needed and desired to more fully develop their therapeutic potential
12/03/2002CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides
12/03/2002CA2263500C Malonate derivatives useful as intermediates for producing isoxazolidinadione hypoglycemic agents
12/03/2002CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094793A1 Acylated 4-aminopyrazoles
11/28/2002WO2002094792A1 Herbicidal substituted benzoylpyrazoles
11/28/2002WO2002094791A1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring
11/28/2002WO2002094266A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
11/28/2002WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002WO2002057223A3 Compounds azepane, preparation method therefor and pharmaceutical compositions containing said compounds
11/28/2002WO2002050069A3 Sulfonylpyrroles for controlling microorganisms
11/28/2002WO2002048106A3 Isoindolin-1-one glucokinase activators
11/28/2002WO2001092219A1 Glycinamides
11/28/2002US20020177707 Aminoaryl oxazolidinone n-oxides
11/28/2002US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002US20020177610 Hypolipidemics; treating obesity and disorders of lipid metabolism
11/28/2002US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example
11/28/2002US20020177595 Novel compounds useful as neuro-protective agents
11/28/2002US20020177594 Inhibitors of histone deacetylase
11/28/2002US20020177589 Novel amines as histamine-3 receptor ligands and their therapeutic applications
11/28/2002US20020177559 Inhibitors of cellular efflux pumps of microbes
11/28/2002DE10138577A1 New 4-benzoyl-5-oxy-pyrazole derivatives, useful as herbicides, especially pre- and post-emergence selective herbicides
11/28/2002CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002CA2447674A1 Herbicidal substituted benzoylpyrazoles
11/28/2002CA2447103A1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002CA2447020A1 The use of 4-aminopyridine derivatives for the treatment of mglur5 receptor mediated diseases
11/28/2002CA2446801A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
11/28/2002CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002CA2410627A1 Glycinamides
11/27/2002EP1260512A1 Novel cyclic amide derivatives
11/27/2002EP1260223A1 Taxanes having furyl or thienyl substituted side-chain
11/27/2002EP1259496A1 (hetero)aryl-substituted heterocyclic enaminones, production thereof and use thereof as herbicides, acaricides and insecticides
11/27/2002EP1259491A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates and amides and their use as alpha-1a agonists
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1001934B1 Indole compounds as cox-2 inhibitors
11/27/2002EP0844825B1 Insecticidal n-(substituted arylmethyl)-4- bis(substituted phenyl or pyridyl)methyl]piperidines
11/27/2002CN1382150A Hydromycin derivatives
11/27/2002CN1382140A Neurotrophic pyrrolidines and piperidines and related compositions containing them
11/27/2002CN1382139A Method and intermediate for preparing is-a-oxazole formylamine and its analogue
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002CN1381454A Method for preparing oxazolidone amine
11/27/2002CN1094939C Microbiocidal benzotriazoles compounds, making method and use
11/26/2002US6486199 Spiro and dispiro 1,2,4-trioxolane antimalarials
11/26/2002US6486187 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
11/26/2002US6486180 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2002US6486173 Serotonin-7 (5-ht7); treatment of central nervous system disorders such as sleep disorders, depression and schizophrenia; for example 1,3-dihydro-2-((4-(4-fluorophenyl)-4-oxobutyl))isoindole
11/26/2002CA2262502C 6-phenyltetrahydro-1,3-oxazin-2-one derivatives and pharmaceutical composition containing the same
11/26/2002CA2148103C Process for preparing taxane derivatives
11/26/2002CA2055174C Process for the synthesis of alpha-((dialkylamino) substituted-methylene)-beta-oxo-(substituted) propanenitriles
11/25/2002WO2001090087A1 Heterocyclic compounds
11/25/2002CA2410382A1 Heterocyclic compounds
11/21/2002WO2002092595A1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002WO2002092581A1 Heterocyclyl phenyl benzyl ethers used as fungicides
11/21/2002WO2002092575A1 Benzimidazole compounds and antiviral uses thereof
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002WO2002092084A1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes
11/21/2002WO2002062290A3 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
11/21/2002WO2002053528A8 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines